Total Payments
$311,712
2024 Payments
$6,825
Companies
17
Transactions
236
Medicare Patients
2,279
Medicare Billing
$236,989
Payment Breakdown by Category
Consulting$155,510 (49.9%)
Other$134,290 (43.1%)
Travel$15,797 (5.1%)
Food & Beverage$6,003 (1.9%)
Education$112.44 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $155,510 | 23 | 49.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $134,290 | 56 | 43.1% |
| Travel and Lodging | $15,797 | 77 | 5.1% |
| Food and Beverage | $6,003 | 78 | 1.9% |
| Education | $112.44 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valencia Technologies Corporation | $94,337 | 1 | $0 (2023) |
| Allergan, Inc. | $52,796 | 62 | $0 (2021) |
| Astellas Pharma US Inc | $51,799 | 48 | $0 (2018) |
| Avadel Specialty Pharmaceuticals, LLC | $40,642 | 35 | $0 (2018) |
| UROVANT SCIENCES INC | $26,915 | 37 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $13,522 | 14 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $12,248 | 6 | $0 (2024) |
| ABBVIE INC. | $7,273 | 6 | $0 (2022) |
| Antares Pharma, Inc. | $4,515 | 2 | $0 (2021) |
| Hologic, LLC | $4,367 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,825 | 2 | Sumitomo Pharma America, Inc. ($6,825) |
| 2023 | $99,760 | 5 | Valencia Technologies Corporation ($94,337) |
| 2022 | $21,210 | 31 | UROVANT SCIENCES INC ($13,912) |
| 2021 | $20,354 | 19 | UROVANT SCIENCES INC ($13,003) |
| 2020 | $16,564 | 15 | Allergan, Inc. ($5,978) |
| 2019 | $20,161 | 33 | Allergan Inc. ($12,190) |
| 2018 | $79,389 | 75 | Avadel Specialty Pharmaceuticals, LLC ($40,642) |
| 2017 | $47,450 | 56 | Astellas Pharma US Inc ($27,808) |
All Payment Transactions
236 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| Category: UROLOGY | ||||||
| 01/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,275.00 | General |
| Category: UROLOGY | ||||||
| 11/16/2023 | Sumitomo Pharma America, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,364.49 | General |
| 10/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Travel and Lodging | In-kind items and services | $611.80 | General |
| Category: Urology | ||||||
| 10/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Travel and Lodging | In-kind items and services | $404.38 | General |
| Category: Urology | ||||||
| 10/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Travel and Lodging | In-kind items and services | $42.00 | General |
| Category: Urology | ||||||
| 03/02/2023 | Valencia Technologies Corporation | eCoin Device Kit (Device) | Consulting Fee | Dividend, profit or other return on investment | $94,337.00 | General |
| Category: Treat Urgency Urinary Incontinence | ||||||
| 10/20/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| Category: Urology | ||||||
| 10/14/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| Category: Urology | ||||||
| 08/24/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $8.56 | General |
| Category: Urology | ||||||
| 07/21/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| Category: Urology | ||||||
| 07/21/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,540.00 | General |
| Category: Urology | ||||||
| 07/21/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Travel and Lodging | Cash or cash equivalent | $335.45 | General |
| Category: Urology | ||||||
| 07/21/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Travel and Lodging | Cash or cash equivalent | $108.00 | General |
| Category: Urology | ||||||
| 07/21/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Travel and Lodging | Cash or cash equivalent | $26.91 | General |
| Category: Urology | ||||||
| 07/21/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Travel and Lodging | Cash or cash equivalent | $3.80 | General |
| Category: Urology | ||||||
| 07/12/2022 | ConvaTec Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: CONTINENCE CARE | ||||||
| 06/27/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Travel and Lodging | Cash or cash equivalent | $35.68 | General |
| Category: Urology | ||||||
| 06/27/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Travel and Lodging | Cash or cash equivalent | $3.80 | General |
| Category: Urology | ||||||
| 06/24/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: Urology | ||||||
| 06/22/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $120.46 | General |
| Category: Urology | ||||||
| 06/21/2022 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,067.50 | General |
| Category: UROLOGY | ||||||
| 06/20/2022 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $915.00 | General |
| Category: UROLOGY | ||||||
| 06/16/2022 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $2,135.00 | General |
| Category: UROLOGY | ||||||
| 06/16/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $83.89 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 470 | 602 | $115,803 | $53,295 |
| 2021 | 11 | 828 | 1,183 | $227,286 | $98,769 |
| 2020 | 13 | 981 | 1,298 | $262,397 | $84,925 |
Total Patients
2,279
Total Services
3,083
Medicare Billing
$236,989
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 159 | 223 | $27,786 | $15,575 | 56.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 89 | 121 | $21,175 | $13,691 | 64.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 46 | $8,050 | $4,874 | 60.5% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2022 | 28 | 34 | $14,348 | $4,283 | 29.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 28 | 28 | $8,764 | $3,989 | 45.5% |
| 52281 | Dilation of urethra using an endoscope | Facility | 2022 | 34 | 35 | $13,265 | $3,909 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 55 | $7,003 | $3,473 | 49.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $4,382 | $2,192 | 50.0% |
| 51727 | Complex measurement of pressure of urine flow in bladder with urethra pressure studies | Facility | 2022 | 12 | 12 | $4,308 | $680.78 | 15.8% |
| 51726 | Complex measurement of pressure of urine flow in bladder | Facility | 2022 | 12 | 12 | $3,432 | $505.09 | 14.7% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2022 | 19 | 22 | $3,290 | $123.32 | 3.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 154 | 238 | $43,771 | $28,055 | 64.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 206 | 366 | $47,755 | $27,223 | 57.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 55 | 80 | $15,271 | $8,876 | 58.1% |
| 52287 | Examination with injections of chemical for destruction of bladder using an endoscope | Facility | 2021 | 40 | 59 | $24,898 | $8,052 | 32.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 99 | $13,248 | $7,653 | 57.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 44 | 44 | $13,915 | $6,677 | 48.0% |
| 52281 | Dilation of bladder canal (urethra) using an endoscope | Facility | 2021 | 36 | 38 | $18,052 | $4,653 | 25.8% |
| 51729 | Complex measurement of pressure of urine flow in bladder (cystometrogram) with bladder canal (urethra) pressure and voiding pressure studies | Facility | 2021 | 19 | 19 | $8,113 | $2,110 | 26.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $3,756 | $1,676 | 44.6% |
| 51726 | Complex measurement of pressure of urine flow in bladder (cystometrogram) | Facility | 2021 | 25 | 25 | $7,534 | $977.62 | 13.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 19 | 19 | $1,221 | $869.31 | 71.2% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2021 | 92 | 124 | $18,272 | $783.59 | 4.3% |
| 51797 | Insertion of device into the abdomen with measurement of pressure and urine flow rate | Facility | 2021 | 20 | 20 | $3,500 | $686.24 | 19.6% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Facility | 2021 | 20 | 20 | $5,140 | $326.00 | 6.3% |
About Dr. Peter Sand, M.D
Dr. Peter Sand, M.D is a Urogynecology and Reconstructive Pelvic Surgery healthcare provider based in Skokie, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700984408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Sand, M.D has received a total of $311,712 in payments from pharmaceutical and medical device companies, with $6,825 received in 2024. These payments were reported across 236 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($155,510).
As a Medicare-enrolled provider, Sand has provided services to 2,279 Medicare beneficiaries, totaling 3,083 services with total Medicare billing of $236,989. Data is available for 3 years (2020–2022), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Urogynecology and Reconstructive Pelvic Surgery
- Location Skokie, IL
- Active Since 09/20/2006
- Last Updated 11/01/2019
- Taxonomy Code 207VF0040X
- Entity Type Individual
- NPI Number 1700984408
Products in Payments
- eCoin Device Kit (Device) $94,337
- BOTOX (Biological) $44,600
- Noctiva (Drug) $40,642
- GEMTESA (Drug) $34,798
- Myrbetriq (Drug) $27,808
- NOCDURNA (Drug) $13,537
- BOTOX (Drug) $12,190
- MYRBETRIQ (Drug) $10,099
- MIRABEGRON (Drug) $9,484
- XYOSTED (Drug) $4,500
- SUNOSI (Drug) $1,719
- FEMALE INCONTINENCE (Device) $726.40
- BOTOX OAB (Drug) $437.10
- ALTIS (Device) $280.15
- Urgent PC (Device) $246.76
- BOTOX - UROLOGY (Drug) $241.66
- ADVANTAGE FIT (Device) $126.16
- VESICARE (Drug) $29.08
- GENTLECATH (Device) $25.52
- RESTORELLE (Device) $23.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urogynecology and Reconstructive Pelvic Surgery Doctors in Skokie
Roger Goldberg, M.d, M.D
Urogynecology and Reconstructive Pelvic Surgery — Payments: $4.1M
Urogynecology and Reconstructive Pelvic Surgery $4.1M
Dr. Sonia Dutta, Md, MD
Urogynecology and Reconstructive Pelvic Surgery — Payments: $3,003
Urogynecology and Reconstructive Pelvic Surgery $3,003
Dr. Ghazaleh Rostami Nia, Md, MD
Urogynecology and Reconstructive Pelvic Surgery — Payments: $775.84
Urogynecology and Reconstructive Pelvic Surgery $775.84